• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatrics . Utilization and Impact of Symptomatic and Exposure SARS-CoV-2 Testing in K-12 Schools

tetano

Editor, Senior Moderator
Pediatrics


. 2023 Jul 1;152(Suppl 1):e2022060352I.
doi: 10.1542/peds.2022-060352I. Utilization and Impact of Symptomatic and Exposure SARS-CoV-2 Testing in K-12 Schools

Jennifer E Schuster[SUP] 1 [/SUP], Tyler R Erickson[SUP] 2 [/SUP], Jennifer L Goldman[SUP] 1 [/SUP], Daniel K Benjamin[SUP] 3 4 [/SUP], M Alan Brookhart[SUP] 2 [/SUP], Stephen Dewhurst[SUP] 5 [/SUP], Alex Fist[SUP] 3 [/SUP], John Foxe[SUP] 6 [/SUP], Maya Godambe[SUP] 7 [/SUP], Lisa Gwynn[SUP] 8 [/SUP], Susan M Kiene[SUP] 9 [/SUP], Dana Keener Mast[SUP] 10 [/SUP], Corinne McDaniels-Davidson[SUP] 9 [/SUP], Jason G Newland[SUP] 7 [/SUP], Eyal Oren[SUP] 9 [/SUP], Rangaraj Selvarangan[SUP] 11 [/SUP], Nidhi Shinde[SUP] 7 [/SUP], Tyler Walsh[SUP] 7 [/SUP], Treymayne Watterson[SUP] 7 [/SUP], Martin Zand[SUP] 12 [/SUP], Kanecia O Zimmerman[SUP] 2 [/SUP], Ibukunoluwa C Kalu[SUP] 2 [/SUP]



Affiliations
Abstract

Objectives: The Centers for Disease Control and Prevention recommend that schools can offer severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostic (on-demand) testing for students and staff with coronavirus disease 2019 symptoms or exposures. Data related to the uptake, implementation, and effect of school-associated on-demand diagnostic testing have not been described.
Methods: The Rapid Acceleration of Diagnostics Underserved Populations Return to School program provided resources to researchers to implement on-demand SARS-CoV-2 testing in schools. This study describes the strategies used and uptake among the different testing programs. Risk of positivity was compared for symptomatic and exposure testing during the δ and ο variant periods. We estimated the number of school absence days saved with school-based diagnostic testing.
Results: Of the 16 eligible programs, 7 provided school-based on-demand testing. The number of persons that participated in these testing programs is 8281, with 4134 (49.9%) receiving >1 test during the school year. Risk of positivity was higher for symptomatic testing compared with exposure testing and higher during the ο variant predominant period compared with the δ variant predominant period. Overall, access to testing saved an estimated 13 806 absent school days.
Conclusions: School-based on-demand SARS-CoV-2 testing was used throughout the school year, and nearly half the participants accessed testing on more than 1 occasion. Future studies should work to understand participant preferences around school-based testing and how these strategies can be used both during and outside of pandemics.


 
Back
Top Bottom